Ma Liansheng, Niu Xiaoyuan, Zhang Wei, Fang Yalan, Wang Jie
Department of Neurology, First Hospital, Shanxi Medical University, Taiyuan, 030000, People's Republic of China.
BMC Health Serv Res. 2017 May 18;17(1):358. doi: 10.1186/s12913-017-2300-6.
Limitations in physicians' knowledge regarding fibrinolytic therapy for acute ischemic stroke may contribute to low rate of fibrinolytic therapy in China. Here physicians' knowledge was surveyed on intravenous fibrinolytic therapy for acute ischemic stroke.
Neurologists (n = 175) from 27 major general hospitals in Shanxi province, P. R. China, were invited to complete questionnaires regarding their basic knowledge of intravenous fibrinolytic therapy for acute ischemic stroke. The questionnaire contained 12 multiple-choice questions. One point was assigned for a correct answer and zero point for a false or unanswered question.
One hundred and thirty-one neurologists (74.9%) responded to the questionnaires. The mean accuracy rate of 12 questions was 54.9 ± 25.01% (range 0.8-96.2%). The mean total score for respondents was 6.59 ± 2.03 (range 2-11). More years of experience and higher academic degrees were independent factors related to the total scores (P = 0.000 and P = 0.004, respectively).
The neurologists in this study were knowledge deficient in the area of intravenous fibrinolytic therapy for acute ischemic stroke. This partially accounts for the low rate of fibrinolytic therapy in China.
医生对急性缺血性脑卒中溶栓治疗的知识局限性可能导致中国溶栓治疗率较低。在此对医生关于急性缺血性脑卒中静脉溶栓治疗的知识进行了调查。
邀请来自中国山西省27家大型综合医院的175名神经科医生填写关于急性缺血性脑卒中静脉溶栓治疗基本知识的问卷。问卷包含12道多项选择题。答对一题得1分，答错或未答得0分。
131名神经科医生（74.9%）回复了问卷。12道题的平均正确率为54.9±25.01%（范围0.8 - 96.2%）。受访者的平均总分是6.59±2.03（范围2 - 11）。更多的工作年限和更高的学历是与总分相关的独立因素（分别为P = 0.000和P = 0.004）。
本研究中的神经科医生在急性缺血性脑卒中静脉溶栓治疗方面知识存在欠缺。这部分解释了中国溶栓治疗率较低的原因。
